两例肺癌患者早期COVID-19肺炎的肺部病理
该研究回顾性分析了两例近期接受肺叶切除术的腺癌患者,发现其术中已存在COVID-19。病理显示除肿瘤外,肺部有水肿、蛋白性渗出物、肺泡上皮细胞局灶性反应性增生伴斑片状炎细胞浸润及多核巨细胞,透明膜不显著。因患者术中无肺炎症状,这些改变可能代表COVID-19肺炎早期肺部病理。
要点
- 两例肺癌患者术后回顾确诊COVID-19,提供早期病理样本。
- 病理见水肿、蛋白性渗出、肺泡上皮增生、炎细胞浸润及多核巨细胞。
- 透明膜不显著,提示早期COVID-19肺炎病理特征。
核心结论
- 两例肺癌患者术中已存在COVID-19,肺部病理显示水肿、蛋白性渗出、肺泡上皮反应性增生、斑片状炎细胞浸润及多核巨细胞,透明膜不显著,可能代表早期COVID-19肺炎。
研究设计与样本
- 回顾性分析两例近期接受肺叶切除术的腺癌患者,术后发现术中已患COVID-19。
主要发现
- 两例患者肺部除肿瘤外均有水肿、蛋白性渗出物、肺泡上皮细胞局灶性反应性增生伴斑片状炎细胞浸润及多核巨细胞。
- 透明膜不显著。
- 两例患者术中均无肺炎症状。
临床怎么用
- 对接受肺叶切除术的肺癌患者,若术后确诊COVID-19,其肺部病理可能呈现早期COVID-19肺炎特征,应结合临床评估。
局限性
- 仅基于两例患者,样本量小;为回顾性分析,术中未行COVID-19检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
There is currently a lack of pathologic data on the novel coronavirus (severe acute respiratory syndrome coronavirus 2) pneumonia, or coronavirus disease 2019 (COVID-19), from autopsy or biopsy. Two patients who recently underwent lung lobectomies for adenocarcinoma were retrospectively found to have had COVID-19 at the time of the operation. These two cases thus provide important first opportunities to study the pathology of COVID-19. Pathologic examinations revealed that apart from the tumors, the lungs of both patients exhibited edema, proteinaceous exudate, focal reactive hyperplasia of pneumocytes with patchy inflammatory cellular infiltration, and multinucleated giant cells. Hyaline membranes were not prominent. Because both patients did not exhibit symptoms of pneumonia at the time of operation, these changes likely represent an early phase of the lung pathology of COVID-19 pneumonia.
引用
- Tian S, Hu W, Niu L, et al. Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer. J Thorac Oncol. 2020. PMID: 32114094. doi:10.1016/j.jtho.2020.02.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。